Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07209501) titled 'Evaluating the Feasibility and Acceptability of Inhalation Aromatherapy for Patients Undergoing Autologous Haematopoietic Stem Cell Transplant (HSCT)' on Oct. 2.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Supportive Care. Masking: Single (Participant).
Primary Sponsor: Singapore General Hospital
Condition:
Chemotherapy-Induced Nausea and Vomiting (CINV)
Intervention:
Other: Aromatherapy inhaler
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: May 15, 2025
Target Sample Size: 30
Countries of Recruitment:
S...